Locations
Overland Park, KS, USA · Kansas City, KS, USA
industry
Pharmaceuticals
Size
51-200 employees
Stage
IPO
founded in
1968
Over the last fifty years, Parnell has become a leading global veterinary pharmaceutical business marketing products in 15 countries. We have built a fully integrated animal health platform with a strong track record in R&D, clinical science, regulatory processes, and with recent FDA accreditation of our sterile manufacturing facility in Sydney, Australia, we can bring innovative solutions to market swiftly. Parnell has also developed unique digital technology solutions that integrate with our innovative products to offer veterinarians and animal owners superior solutions to their animal health needs. Parnell has a market-leading portfolio of products for companion, performance, and production animals. We currently market innovative cattle breeding programs as well as osteoarthritis solutions for dogs. In addition, we have an impressive pipeline spanning anesthesia, anti-microbials, orthopedics, and laminitis. Parnell has a strong focus on personal and professional development for those.
Something looks off?